SCHEMBL22807293

SCHEMBL22807293

COc1cc(OC)c(F)c(COc2ccc(NC(=O)O)nc2)c1F

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 10/20 0.60
▸ FGFR4 P22455 10/20 0.52
▸ CYP3A4 P08684 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ MITF O75030 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ FGFR3 P22607 2/20 0.44
▸ FGFR2 P21802 1/20 0.44
▸ ABCB1 P08183 1/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ MET P08581 3/20 0.41
▸ DEGS1 O15121 1/20 0.41
▸ GRM5 P41594 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29733429 0.85 FGFR1 (0.56) FGFR1FGFR4CYP3A4CYP2C9CYP2C19
SCHEMBL18131773 0.78 FGFR4 (0.80) FGFR1FGFR4CYP3A4CYP2C9CYP2C19
SCHEMBL22828278 0.77 FGFR1 (0.48) FGFR1FGFR4CYP3A4CYP2C9CYP2C19
SCHEMBL18131770 0.76 FGFR4 (0.81) FGFR1FGFR4CYP3A4CYP2C9CYP2C19
SCHEMBL28696599 0.76 FGFR1 (0.47) FGFR1FGFR4CYP3A4CYP2C9CYP2C19
SCHEMBL4074720 0.76 DEGS1 (0.55) NPC1RAB9AMITFTP53GAA
SCHEMBL22807283 0.76 FGFR3 (0.45) FGFR1FGFR4CYP3A4CYP2C9CYP2C19
SCHEMBL22807284 0.76 FGFR3 (0.45) FGFR1FGFR4CYP3A4CYP2C9CYP2C19
SCHEMBL29489954 0.76 FGFR3 (0.45) FGFR1FGFR4CYP3A4CYP2C9CYP2C19
SCHEMBL18131765 0.76 FGFR1 (0.45) FGFR1FGFR4CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3986405-A1 COMPOUNDS FOR INHIBITING FGFR4 Terns Pharmaceuticals, Inc. (US) 2022-04-27 — — EP disclosed
WO-2020257527-A1 COMPOUNDS FOR INHIBITING FGFR4 Terns, Inc. (US) 2020-12-24 — — WO disclosed
Send feedback